Of cancer patients harboring WT TP53, those with high MMP9 mRNA and low p53 protein expression showed a significantly increased risk of death when compared to those with low MMP9 mRNA and high p53 protein expression (the median overall survival was 112.1 and 146.1 months, respectively) (Fig. S5H, right). This evidence concerns the gene TP53 and cancer.